Literature DB >> 9083234

Aiding fluid prescription for the dysnatremias.

H J Adrogué1, N E Madias.   

Abstract

OBJECTIVE: The goal of the present study was to develop a novel approach that facilitates the prescription of fluid therapy in patients with abnormal serum sodium concentration. METHODOLOGY AND
RESULTS: The novel approach is based on a simple equation, derived from established principles on the distribution of sodium in body fluids, that estimates the impact of a unit dose, i.e., 1 l of any infusate on the patient's serum sodium concentration. In accordance with the equation, the expected change in the patient's serum sodium concentration in response to 1 l of any infusate (delta[Na+]s) is obtained by subtracting the sodium concentration of the patient's serum from the sodium concentration of the infusate, each expressed in mEq/l, and dividing the result by the patient's estimated total body water expressed in liters (adding 1 l to account for the volume of the infusate). The amount of the particular infusate to be administered over the course of any given time period can be easily computed by dividing the desired delta[Na+]s at the end of the period by the calculated delta[Na+]s effected by 1 l of the infusate. The utility and limitations of the proposed approach are presented.
CONCLUSIONS: The novel equation is not a means for formulating therapy. Rather, it provides, simply and expeditiously, quantitative projections that can assist the physician in implementing the selected treatment plan for patients with dysnatremias.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083234     DOI: 10.1007/s001340050333

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  23 in total

Review 1.  Hyponatraemia in clinical practice.

Authors:  M Biswas; J S Davies
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

Review 2.  Fluid and electrolyte overload in critically ill patients: An overview.

Authors:  Bruno Adler Maccagnan Pinheiro Besen; André Luiz Nunes Gobatto; Lívia Maria Garcia Melro; Alexandre Toledo Maciel; Marcelo Park
Journal:  World J Crit Care Med       Date:  2015-05-04

Review 3.  Improving on the Adrogué-Madias Formula.

Authors:  Sheldon Chen; Michael Shieh; Robert Chiaramonte; Jason Shey
Journal:  Kidney360       Date:  2020-12-04

4.  Characteristics, therapies, and factors influencing outcomes of hospitalized hypernatremic geriatric patients.

Authors:  Muhammad R Toor; Anjali Singla; Maria V DeVita; Jordan L Rosenstock; Michael F Michelis
Journal:  Int Urol Nephrol       Date:  2014-05-10       Impact factor: 2.370

Review 5.  Preventing neurological complications from dysnatremias in children.

Authors:  Michael L Moritz; J Carlos Ayus
Journal:  Pediatr Nephrol       Date:  2005-08-04       Impact factor: 3.714

6.  Management of hyponatremia in various clinical situations.

Authors:  Michael L Moritz; Juan C Ayus
Journal:  Curr Treat Options Neurol       Date:  2014-09       Impact factor: 3.598

7.  Increased mortality in hypernatremic burned patients.

Authors:  Thomas Namdar; Frank Siemers; Peter L Stollwerck; Felix H Stang; Peter Mailänder; Thomas Lange
Journal:  Ger Med Sci       Date:  2010-06-07

Review 8.  Hypertonicity: Pathophysiologic Concept and Experimental Studies.

Authors:  Christos Argyropoulos; Helbert Rondon-Berrios; Dominic S Raj; Deepak Malhotra; Emmanuel I Agaba; Mark Rohrscheib; Zeid Khitan; Glen H Murata; Joseph I Shapiro; Antonios H Tzamaloukas
Journal:  Cureus       Date:  2016-05-02

9.  Effects of Tissue Sodium Storage on Plasma Sodium Concentration in Response to Hypo- and Hypertonic Stimuli.

Authors:  Rosa D Wouda; Rik H G Olde Engberink; Eliane F E Wenstedt; Jetta J Oppelaar; Liffert Vogt
Journal:  Nephron       Date:  2021-06-18       Impact factor: 2.847

10.  Continuous controlled-infusion of hypertonic saline solution in traumatic brain-injured patients: a 9-year retrospective study.

Authors:  Antoine Roquilly; Pierre Joachim Mahe; Dominique Demeure Dit Latte; Olivier Loutrel; Philippe Champin; Christelle Di Falco; Athanase Courbe; Kevin Buffenoir; Olivier Hamel; Corinne Lejus; Véronique Sebille; Karim Asehnoune
Journal:  Crit Care       Date:  2011-10-28       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.